The present invention is generally directed to deuterated agonists and their methods of use. It is more specifically directed to deuterated alpha-7 nicotinic receptor agonists and their methods of use. In one aspect, the present invention involves compounds of the structure
1
-
34
as shown in FIGS.
1
-
4.
In another aspect, the present invention involves the treatment of a disorder with a compound of the structure
1
-
34
as shown in FIGS.
1
-
4.
Montero, Jean-Louis; Bello-Roufai, Nassirou; Leydet, Alain, Bulletin de la Societe Chimique de France, 1987, # 2, p. 302 - 308
作者:Montero, Jean-Louis、Bello-Roufai, Nassirou、Leydet, Alain、Dewynter, Georges、N'Guessan, Thomas Yao、Winternitz, Francois